A comprehensive view of Vaccination/Immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna signs 10-year agreement with Australian federal government, Victorian government to work with Monash University to develop mRNA vaccine manufacturing plant; new plant to make up to 100 million respiratory virus vaccines annually

Merck collaborating with biotechnology firm Orna Therapeutics to develop, commercialize infectious disease, oncology vaccines and therapeutics based on Orna’s oRNA technology; Merck paid Orna US$150.0M upfront as part of deal

Novavax seeks FDA approval for its protein-based NVX-CoV2373 COVID-19 vaccine for use as a booster dose in adults; the FDA approved the vaccine for emergency use in the US in July

British regulator 1st to OK Moderna's updated COVID booster

European Medicine Agency starts rolling review of Pfizer and Biontech’s BA.4/5 Omicron-adapted COVID-19 vaccine candidate; the companies are manufacturing two versions of the vaccine based on different Omicron subvariants

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count